Nuveen Asset Management’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-28,308
| Closed | -$679K | – | 3313 |
|
|
2021
Q1 | $679K | Buy |
28,308
+4,804
| +20% | +$115K | ﹤0.01% | 3015 |
|
|
2020
Q4 | $693K | Buy |
23,504
+238
| +1% | +$7.02K | ﹤0.01% | 2929 |
|
|
2020
Q3 | $356K | Buy |
23,266
+5,099
| +28% | +$78K | ﹤0.01% | 3042 |
|
|
2020
Q2 | $455K | Sell |
18,167
-1,143
| -6% | -$28.6K | ﹤0.01% | 2936 |
|
|
2020
Q1 | $394K | Buy |
19,310
+17
| +0.1% | +$347 | ﹤0.01% | 2849 |
|
|
2019
Q4 | $596K | Sell |
19,293
-133
| -0.7% | -$4.11K | ﹤0.01% | 2865 |
|
|
2019
Q3 | $649K | Sell |
19,426
-1,076
| -5% | -$35.9K | ﹤0.01% | 2864 |
|
|
2019
Q2 | $656K | Buy |
+20,502
| New | +$656K | ﹤0.01% | 2903 |
|